HealthcareServices

Sexually Transmitted Diseases (STD) Testing Market Forecast: What to Expect by 2029

November 14, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Forecasted Market Size Estimates For The Sexually Transmitted Diseases (STD) Testing Market Between 2025 And 2029?

The sexually transmitted diseases (std) testing market has experienced robust expansion in recent years. Projections indicate its expansion from $8.08 billion in 2024 to $8.78 billion in 2025, reflecting an 8.6% compound annual growth rate (CAGR). Historically, this expansion has been driven by factors such as urbanization and denser populations, an older demographic engaging in active sexual lives, governmental efforts to encourage STD screening, the incorporation of STD testing into standard medical examinations, and enhanced financial support for public health initiatives.

The sexually transmitted diseases (std) testing market is projected to expand significantly over the coming years. Its valuation is anticipated to reach $12.08 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 8.3%. This projected expansion during the forecast period stems from several factors, including the escalating global incidence of STDs, a heightened awareness regarding sexual health, the widespread occurrence of asymptomatic infections, an expanding demographic of sexually active adolescents and young adults, and an increase in high-risk sexual behaviors. Key trends expected within the forecast timeframe encompass the progress in rapid and point-of-care testing, the introduction of home-based STD testing kits, improvements in molecular diagnostic techniques, the integration of automation and AI in diagnostic laboratories, and enhanced sensitivity and specificity of newly developed test kits.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24695&type=smp

What Are The Top Growth Drivers Impacting The Sexually Transmitted Diseases (STD) Testing Market Outlook?

The increasing incidence of HIV is projected to drive the expansion of the sexually transmitted diseases (STD) testing market in the upcoming period. This virus compromises the immune system by targeting and eliminating vital white blood cells, thereby increasing the body’s susceptibility to various infections and illnesses. A decrease in awareness and prevention initiatives has led to an uptick in HIV infections, as more individuals engage in unsafe practices like unprotected sex and fewer people undergo testing, particularly among younger demographics. This surge in HIV cases consequently bolsters the need for sexually transmitted disease (STD) testing, fostering greater public and medical sector vigilance, which encourages more people to pursue thorough screenings for early detection and to curtail further spread. For instance, a report from July 2024 by the Joint United Nations Programme on HIV/AIDS (UNAIDS), a Switzerland-based government body, revealed that approximately 1.3 million individuals contracted HIV for the first time in 2023. This figure is nearly three times the 2025 goal of fewer than 370,000 new cases. Consequently, the escalating prevalence of HIV will stimulate the growth of the sexually transmitted diseases (STD) testing market.

How Is The Sexually Transmitted Diseases (STD) Testing Market Classified Into Different Segments?

The sexually transmitted diseases (STD) testing market covered in this report is segmented –

1) By Product: Instruments And Services, Consumables, Software

2) By Technology: Immunoassay, Molecular Diagnostics

3) By Sample Type: Blood Samples, Urine Samples, Swabs, Semen Samples, Other Sample Types

4) By Disease Type: Chlamydia, Gonorrhea, Syphilis, HIV Or AIDS, Herpes Simplex Virus (HSV)

5) By End User: Individuals, Healthcare Providers, Health Insurance Providers, Govement Health Agencies, NGOs And Community Health Organizations

Subsegments:

1) By Instruments And Services: Diagnostic Instruments, Testing Services

2) By Consumables: Reagents And Kits, Specimen Collection Devices, Slides, Tubes, And Other Lab Supplies

3) By Software: Laboratory Information Management Systems (LIMS), Electronic Health Records (EHR) Integration Tools, Data Analysis And Reporting Tools, Patient Management Software

What Trends Are Expected To Drive The Sexually Transmitted Diseases (STD) Testing Market?

Leading companies within the sexually transmitted diseases (STD) testing market are concentrating on developing advanced solutions, such as syphilis testing kits, to expand testing accessibility to a broader demographic. Syphilis testing kits are diagnostic instruments utilized to detect the presence of the Treponema pallidum bacteria, which causes syphilis, through blood samples or other bodily fluids for timely diagnosis and treatment. For example, in August 2023, iHealth Labs Inc., a US-based medical device company, introduced its CheckMeSafe home collection kit for HIV and syphilis testing. This FDA-approved iHealth CheckMeSafe Home Collection kit allows individuals aged 18 and older to collect blood samples for HIV (I, II, P24 antigen) and syphilis testing from the privacy and comfort of their own residence. Users can send their samples to the lab using a prepaid overnight label and receive confidential, reliable results in as quickly as two days. The kit offers highly accurate results, with sensitivity rates reaching 99.9% for HIV and 99.5% for syphilis. All samples are processed in a CLIA-certified and CAP-accredited laboratory, ensuring compliance with strict federal and state quality standards through regular inspections.

Who Are The Primary Competitors In The Global Sexually Transmitted Diseases (STD) Testing Market?

Major companies operating in the sexually transmitted diseases (STD) testing market are F Hoffmann La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Siemens Healthineers AG, Becton Dickinson And Co., Hologic Inc., QuidelOrtho Corp., Bio-Rad Laboratories Inc., Cepheid, OraSure Technologies Inc., Meridian Bioscience Inc., Sekisui Diagnostics Ltd., Trinity Biotech Plc, Chembio Diagnostics Inc., Operon SA, Jal Medical Pte. Ltd., Anatolia Geneworks, CLIAwaived Inc., Avecon Healthcare Pvt. Ltd., AEHEALTH LIMITED.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/sexually-transmitted-diseases-std-testing-global-market-report

Which Global Regions Are Influencing The Competitive Landscape Of The Sexually Transmitted Diseases (STD) Testing Market?

North America was the largest region in the sexually transmitted diseases (STD) testing market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the sexually transmitted diseases (STD) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Sexually Transmitted Diseases (STD) Testing Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24695&type=smp

Browse Through More Reports Similar to the Global Sexually Transmitted Diseases (STD) Testing Market 2025, By The Business Research Company

Sexually Transmitted Infections Stis Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/sexually-transmitted-infections-stis-global-market-report

Liver Diseases Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report

Rare Diseases Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/rare-diseases-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795